Will at least 4 of Nectome's first 20 clients have significant damage?
One-OffHealth & MedicineWissenschaft13JManifold MarketsKein KYCVerifizierte AuflösungsdatenOrdentlich kalibriertAktuelle Community-PrognoseJa 66.7%
Prognostiker
5
Fragetyp
binary
Methodik
Play-money forecasting platform
Quellentyp
Prognose
Marktdaten
Aktualisiert vor 3 Stunden
Veraltet15. Apr. 26, 03:57 UTC15. Apr. 40, 03:45 UTC
Trends
Verwandte Märkte
Verwandte Fragen als Kontext, kein Vergleich gleichwertiger Kontrakte.
In 2029, will at least 75% of Nectome clients be ideally preserved?
Manifold MarketsWill Nectome preserve at least 100 humans by the end of 2030?
Manifold MarketsWill Nectome have at least ten preserved humans by the end of 2027?
Manifold MarketsWill WHO declare Hantavirus a Public Health Emergency of International Concern this Year?
KalshiWhen will Compass Pathways submit a NDA for COMP360 psilocybin?
KalshiWhich countries will report an Ebola case in 2026?
KalshiRegeln
Nectome is a brain preservation startup, comparable to cryonics.
- They are currently debuting their services, which they claim to be much higher quality than other organizations, but they have yet to preserve any clients.
- This market resolves YES if, by 2040 there is strong evidence that at least 4 of the first 20 preservations that Nectome attempts have significant damage such that restoring them to life is either impossible or would result in significant losses to their personality, memory, et cetera.
- If, when the market closes, there is no significant signs of such damage, this market resolves NO.
- If Nectome fails to preserve 20 people I will attempt to resolve N/A. If it's not clear whether there's "strong evidence" I will use my best judgment.
- As such, I won't bet.
Offene Märkte
Health & Medicine
POLYMARKETHantavirus pandemic in 2026?
- No-0.3pt97%
- Yes+0.3pt3%
- Gesamtvolumen
- 15,6 Mio. €
- 24h-Volumen
- 35.620,9 €
KALSHIWill WHO declare Hantavirus a Public Health Emergency of International Concern this Year?
- No97%
- Yes-0.9pt3%
- Gesamtvolumen
- 1,6 Mio. €
- 24h-Volumen
- 5183,7 €
POLYMARKETFDA approves skin cancer vaccine by which date?
- December 31,+4.0pt65%
- September41%
- June28%
- Gesamtvolumen
- 83.504,6 €
KALSHIMeasles cases in 2026?
- Above 300099%
- Above 4000-1.0pt96%
- Above 6000-4.0pt58%
+2 weitere Ergebnisse
- Gesamtvolumen
- 864.245,4 €
- 24h-Volumen
POLYMARKETNew pandemic in 2026?
- No+0.5pt94%
- Yes-0.5pt6%
- Gesamtvolumen
- 915.756,6 €
- 24h-Volumen
- 1507,6 €
KALSHIWhen will the FDA approve Intellia Therapeutics' lonvo-z?
- Before July 2027+67.0pt97%
- Before 202872%
- Before October 202752%
- Gesamtvolumen
- 4192,1 €
- 24h-Volumen
- Will 3 mg THC beverages be federally legal to sell?
- Measles cases in U.S. in 2026?
- Cyclosporiasis cases reported in the US in 2026?
- FDA decision: Bepirovirsen by GlaxoSmithKline (in 2026)
- What will the average number of measles cases be during Trump's term?
- When will the FDA reclassify BPC-157 to Category 1?
- Ebola pandemic in 2026?
- FDA decision: Saroglitazar by Zydus Therapeutics (in 2026)
- When will Compass Pathways submit a NDA for COMP360 psilocybin?
- FDA decision: Ifinatamab Deruxtecan by Daiichi Sankyo (in 2026)
- Will the FDA approve CagriSema?
- FDA decision: Anitocabtagene Autoleucel (anito-cel) by Gilead Sciences (in 2026)
Häufige Fragen
- Wie stehen die aktuellen Quoten für Will at least 4 of Nectome's first 20 clients have significant damage??
- Manifold Markets bewertet Yes mit 67% (Stand: 8. September 2026).
- Wann wird Will at least 4 of Nectome's first 20 clients have significant damage? entschieden?
- Will at least 4 of Nectome's first 20 clients have significant damage? soll am 15. April 2040 entschieden werden.
- Wie wird Will at least 4 of Nectome's first 20 clients have significant damage? abgerechnet?
- Manifold Markets rechnet diesen Markt wie folgt ab: Nectome is a brain preservation startup, comparable to cryonics.